RTI Biologics Adds Christie Blakely, Michael LaPrade to Leadership Team

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq: RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, announced today the addition of Christie Blakely and Michael LaPrade as vice presidents of the company.

MORE ON THIS TOPIC